A GIP/GLP-1/glucagon triple agonist reduced HbA1c by up to 1.9 percentage points at 40 weeks for adults with type 2 diabetes, according to topline results from the TRANSCEND-T2D-1 trial. Retatrutide ...

Tirzepatide provided a larger reduction in HbA1c and greater improvements in multiple cardiometabolic parameters compared with conventional care for adults recently diagnosed with type 2 diabetes, ...

For years, people with prediabetes have been told the same thing: lose weight or risk developing diabetes. But new research flips that idea on its head, showing that blood sugar can return to normal ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Some supplements that can lower blood sugar may lower it too much if you take them with medication. Other supplements may ...

Sugar Harmony: SugarHarmony Research has issued a consumer safety notice after tainted and counterfeit Sugar Harmony products ...

Feb 20 (Reuters) - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) Diabetes ...

CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them at risk for dangerous seizures or loss of consciousness due to severe low ...

The diabetes playbook just got a major update. The International Diabetes Federation officially recognized a fifth form of the disease this year, a landmark step that comes more than 70 years after it ...